C-kit mutations and mast cell disorders. A model of activating mutations of growth factor receptors

Hematology and Cell Therapy

Volumn 39, Issue 2, 1997, Pages 114-116

  Pignon, J M ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

C kit mutations; mastocytosis

Indexed keywords

GROWTH FACTOR RECEPTOR;

ANIMAL CELL; CONFERENCE PAPER; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN CELL; MASTOCYTOMA; MASTOCYTOSIS; MOUSE; NONHUMAN; ONCOGENE C KIT;

EID: 0030789304     PISSN: 14302772     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00282-997-0114-4     Document Type: Conference Paper

References (14)

1. Di Noto R, Lo Pardo C, Schiavone EM, et al (1996) Stem cell receptor (c-kit, CD 117) is expressed on blast cells from most immature types of acute myeloid malignancies but is also a characteristic of a subset of acute promyelocytic leukaemia. Br J Haematol 92: 562-564
2. Fleischmann RA (1992) Human piebald trait resulting from a dominant negative mutant allele of the c-kit membrane receptor gene. J Clin Invest 89: 1713-1717
3. Furitsu T, Tsujimura T, Tono T, et al (1993) Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Inv 92: 1736-1744
4. Galli SJ, Hammel I (1994) Mast cell and basophil development. Current Opinion in Hematol 1: 33-39
5. Giebel LB, Strunk KM, Holmes SA, Spritz RA (1992) Organization and nucleotide sequence of the human c-kit (mast/stem cell growth factor receptor) proto-oncogene. Oncogene 7: 2207-2217
6. Kitayama H, Kanakura Y, Furitsu T, et al (1995) Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independant growth and tumorigenicity of factor-dependant hematopoietic cell lines. Blood 8: 790-798
7. Longley BJ, Tyrrell L, Lu S, et al (1996) Somatic c-kit activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm. Nat Genetics 12: 312-314
8. Metcalfe DD (1991) Classification and diagnosis of mastocytosis: current status. J Inv Dermatol 96: 2S-4S
9. Nagata H, Worobec AS, Chad KO, et al (1995) Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci USA 92: 10560-10564
10. Ogawa MY, Matzusaki S, Nishikawa SI, et al (1991) Expression and function of c-kit in hematopoietic progenitor cells. J Exp Med 174: 63-71
11. Piao X, Bernstein A (1996) A point mutation in the catalytic domain of c-kit induces growth factor independence, tumorigenicity, and differentiation in vitro. Blood 87: 3117-3123
12. Pignon JM, Giraudier S, Duquesnoy P, et al (1997) A new c-kit mutation in a case of aggressive mast cell disease. Br J Haematol 96: 374-376
13. Tsujimura T, Furitsu T, Morimoto M, et al (1994) Ligand-independent activation of c-kit tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation. Blood 83: 2619-2626
14. Yarden Y, Wun-Jing K, Yang-Feng T, et al (1987) Human protooncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 6: 3341-3351